Skip to content

Twist Bioscience

US · TWST #1258 by market cap Listed 2018
155.65 -11.32 -6.78%
Live - 5344 symbols - heartbeat 114s ago · 2026-10-08 06:50
Pre-market 151.80 -2.47%
After-hours 155.50 -0.10%
Overnight 154.61 -0.67%
Market cap
10.32B
P/B
23.15
EPS
-1.30
Reader sentiment Are you bullish or bearish on TWST?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Piper Sandler Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $115
    Market Newswire · 2026/8/5
  • Rating change
    William Blair Maintains Twist Bioscience(TWST.US) With Buy Rating
    Market Newswire · 2026/8/4
  • Form 144 | Twist Bioscience(TWST.US) Officer Proposes to Sell 44.68 Million in Common Stocks
    Market Newswire · 2026/9/18
  • Rating change
    Leerink Partners Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $110
    Market Newswire · 2026/7/17
  • Rating change
    Barclays Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $95
    Market Newswire · 2026/6/24
  • Rating change
    TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $115
    Market Newswire · 2026/8/4
  • Form 144 | Twist Bioscience(TWST.US) Officer Proposes to Sell 9.31 Million in Common Stocks
    Market Newswire · 2026/9/18
  • Rating change
    Leerink Partners Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $110
    Market Newswire · 2026/7/16
  • Rating change
    CCORF Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $120
    Market Newswire · 2026/8/4
  • Rating change
    Evercore Downgrades Twist Bioscience(TWST.US) to Hold Rating, Raises Target Price to $102
    Market Newswire · 2026/7/6
  • Rating change
    Baird Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $115
    Market Newswire · 2026/8/4
  • Rating change
    CCORF Initiates Twist Bioscience(TWST.US) With Buy Rating, Announces Target Price $90
    Market Newswire · 2026/6/15
  • Rating change
    Leerink Partners Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $160
    Market Newswire · 2026/9/17
  • Twist Bioscience(TWST.US) Officer Sells US$56.33 Million in Common Stock
    Market Newswire · 2026/9/22
  • Rating change
    BWS Financial Initiates Twist Bioscience(TWST.US) With Sell Rating, Announces Target Price $45
    Market Newswire · 2026/9/10
  • Leerink Partners Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $190
    Market Newswire · 2026/9/29
  • Rating change
    Guggenheim Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $107
    Market Newswire · 2026/6/29
  • BWS Financial Maintains Twist Bioscience(TWST.US) With Sell Rating, Maintains Target Price $45
    Market Newswire · 2026/9/18
  • Rating change
    CCORF Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $120
    Market Newswire · 2026/7/14
  • Rating change
    TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $89
    Market Newswire · 2026/6/15

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 06:50:15 · For reference only, not investment advice and not tailored to your situation.